SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)
Irina Kislaya(German Center for Infection Research), Carla Manita(National Institute of Health Dr. Ricardo Jorge), Paulo Gonçalves(National Institute of Health Dr. Ricardo Jorge), Rita Matos(Universidade do Porto), Verónica Gomez(National Institute of Health Dr. Ricardo Jorge), Nuno Verdasca(National Institute of Health Dr. Ricardo Jorge), Joana Santos(National Institute of Health Dr. Ricardo Jorge), João Almeida Santos(National Institute of Health Dr. Ricardo Jorge), Mafalda Sousa‐Uva, Ana Paula Rodrigues(Microsoft (Brazil)), Rita de Sousa(Instituto Nacional de Saúde), Marta Barreto(Administração Regional de Saúde de Lisboa e Vale do Tejo), Sofia Soeiro(National Institute of Health Dr. Ricardo Jorge), Rita Roquette, Vânia Gaio(National Institute of Health Dr. Ricardo Jorge), Raquel Guiomar, Ana Rita Torres(National Institute of Health Dr. Ricardo Jorge), Inês Costa
Cited by 16
Related Papers
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case–control study
|Eurosurveillance|2013|198